Skip to main content
. 2017 Oct 27;34(12):2680–2692. doi: 10.1007/s12325-017-0632-6

Table 4.

Symptoms reported spontaneously, selected as most bothersome, and indicative of a diabetic gastroparesis (DGP) medication working (n = 73)

Symptom Spontaneous reportsa Selected as most bothersomeb,c Indicative of DGP medication workingd,e
Bloating 51 (69.9%) 20 (27.4%) 36 (49.3%)
Stomach fullness 43 (58.9%) 5 (6.8%) 14 (19.2%)
Constipation 39 (53.4%) 8 (11.0%) 15 (20.5%)
Vomiting 39 (53.4%) 5 (6.8%) 10 (13.7%)
Upper abdominal pain 38 (52.1%) 12 (16.4%) 13 (17.8%)
Heartburn or reflux 38 (52.1%) 5 (6.8%) 7 (9.6%)
Nausea 36 (49.3%) 11 (15.1%) 16 (21.9%)
Gas 35 (47.9%) 4 (5.5%) 6 (8.2%)
Diarrhea 28 (38.4%) 2 (2.7%) 6 (8.2%)
Regurgitation 22 (30.1%) 1 (1.4%) 1 (1.4%)
Cramping 18 (24.7%) 3 (4.1%) 4 (5.5%)
General abdominal pain/discomfort 18 (24.7%) 1 (1.4%)
Upper abdominal discomfort 16 (21.9%) 2 (2.7%) 4 (5.5%)
Postprandial fullness 15 (20.5%) 1 (1.4%)
Retching 7 (9.6%) 1 (1.4%)

aSpontaneous reports provided only for symptoms selected among the most bothersome

bThe sum of reports is more than 73 as some participants reported more than one most bothersome symptom

cTwo participants were unable to respond, noting that all of their DGP symptoms were the most bothersome

dThe sum of reports is more than 73 as some participants reported more than one symptom needing to improve

eAdditional symptoms that participants reported would indicate that a DGP medication was working included stomach or belly visibly larger (n = 3; 4.1%), lower abdominal pain (n = 1; 1.4%), and regurgitation (n = 1; 1.4%)